Home › Funds › PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. › EBS
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. position in EBS
EMERGENT BIOSOLUTIONS INC · Health Care
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. reported holding 1,143,481 shares of EBS (EMERGENT BIOSOLUTIONS INC) in its Q3 2026 13F filing — a position valued at US$7.5M, representing 0.68% of its reported portfolio and ranking #38 among its reported holdings. PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. has disclosed EBS holdings in 11 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.'s EBS position evolved
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. first disclosed a stake in EBS in Q3 2023 at 299,187 shares (US$1.0M). The position peaked in Q4 2025 at 772,771 shares, worth US$9.6M. Across 11 filings, PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. increased the stake 5 time(s), trimmed it 0 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 1,143,481 shares valued at US$7.5M — an increase of 370,710 shares quarter over quarter.. Notable position changes include a 185% increase in Q4 2023 (shares rose 5% over the following quarter), a 250% increase in Q4 2024 (shares fell 49% over the following quarter), a 199% increase in Q1 2025 (shares rose 31% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 299.19K | $1.02M | New |
| Q4 2023 | 853.35K | $2.05M | Add |
| Q3 2024 | 60.00K | $501.00K | New |
| Q4 2024 | 210.00K | $2.01M | Add |
| Q1 2025 | 627.67K | $3.05M | Add |
| Q2 2025 | 772.77K | $4.93M | Add |
| Q3 2025 | 772.77K | $6.82M | Hold |
| Q4 2025 | 772.77K | $9.55M | Hold |
| Q1 2026 | 772.77K | $6.41M | Hold |
| Q2 2026 | 772.77K | $6.48M | Hold |
| Q3 2026 | 1.14M | $7.55M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About EBS and 13F data
EBS (EMERGENT BIOSOLUTIONS INC) is a Health Care company. 23 other funds we track also report a position in EBS — the largest reported positions include OAK HILL ADVISORS LP (US$9.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
More on PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.
FAQ
How long has PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. held EBS?
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. has disclosed EBS holdings in 11 of the last 13 reported quarters, going back to Q3 2023.
What is PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.'s current position in EBS?
As of Q3 2026, PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. holds 1.14M shares of EBS (EMERGENT BIOSOLUTIONS INC), valued at $7.55M, representing 0.68% of its reported portfolio and ranking #38.
Has PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. been buying or selling EBS?
In the latest 13F filing (Q3 2026), PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. increased its position in EBS. The position peaked in Q4 2025 at 772.77K shares.
Which other funds hold EBS?
Other major institutional holders of EBS include OAK HILL ADVISORS LP, among 23 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.